PANCHSHEEL

Panchsheel Organic financials

Market cap
₹146 Cr
Sector
Healthcare

What Panchsheel Organic Ltd. does

Panchsheel Organics manufactures and exports APIs, intermediates and finished pharmaceutical formulations from a single facility in Indore, Madhya Pradesh, supplying domestic majors and MNCs such as Zydus, Abbott, Swiss Garnier and Ajanta Pharma. Its current product profile spans APIs like Carbamazepine, Irbesartan, Eslicarbazepine Acetate, Nitrofurantoin and Oxcarbazepine, serving anticonvulsant, antibacterial and cardiovascular therapy segments. The company is building a new fermentation plant to add enzymes, probiotics and anti-cancer molecule capabilities alongside its existing API business.

Segments

  • Active Pharmaceutical Ingredients (APIs)
  • Fermentation-based products
Manufacturing facility
1 API plant in Indore, MP - 7,500 sq. mt. land with 4 manufacturing blocks covering 5,000 sq. mt.
Current API product portfolio
10 products
Export presence
15+ countries
New fermentation plant progress
~50% civil work complete; machinery procurement underway; targeted launch Q1 FY25
Industry track record
35+ years in API/pharma manufacturing (founded 1990)
Quality certifications
ISO 9001:2008 certified; GMP & WHO compliant manufacturing
Founded 1990Headquarters Indore, Madhya Pradesh

Quarterly results

Q1 FY27: revenue up 4.7%, net profit down 18.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue27 26 28 24 25 −7%27 +2%31 +10%25 +5%
EBITDA5 5 5 4 4 −32%4 −17%2 −49%3 −11%
Net profit4 4 3 3 3 −31%4 +0%2 −46%2 −19%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −12.1% 90D

₹28.0₹30.0₹32.0₹34.029 Oct10 Nov23 Nov7 Dec21 Dec4 Jan19 Jan

90D: ₹33 on 29 Oct 2014 → ₹29. High ₹33.75 (2 Nov 2014), low ₹27.15 (23 Dec 2014).

Financials, as filed

Revenue grew 0.7% a year over 2 years, FY24 to FY26. Operating margin narrowed to 12.6%.

Year endingFY24FY25FY26
Revenue₹105 Cr₹108 Cr₹107 Cr
Operating profit₹19 Cr₹19 Cr₹13 Cr
Operating margin18.0%17.5%12.6%
Interest₹0 Cr₹0 Cr₹0 Cr
Depreciation₹2 Cr₹2 Cr₹2 Cr
Net profit₹14 Cr₹14 Cr₹11 Cr
Net margin13.4%13.0%10.2%
Cash from operations₹10 Cr₹4 Cr₹10 Cr
Free cash flow₹0 Cr₹-12 Cr₹3 Cr
ROCE17.0%14.0%10.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹5 Cr₹10 Cr₹12 Cr₹13 Cr₹13 Cr₹13 Cr
Reserves₹35 Cr₹37 Cr₹84 Cr₹112 Cr₹125 Cr₹128 Cr
Borrowings₹4 Cr₹4 Cr₹6 Cr₹6 Cr₹4 Cr₹6 Cr
Other liabilities₹14 Cr₹22 Cr₹21 Cr₹28 Cr₹29 Cr₹25 Cr
Total liabilities₹58 Cr₹74 Cr₹123 Cr₹159 Cr₹171 Cr₹172 Cr
Fixed assets₹7 Cr₹7 Cr₹8 Cr₹14 Cr₹19 Cr₹20 Cr
Capital work in progress₹2 Cr₹2 Cr₹4 Cr₹6 Cr₹17 Cr₹17 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹0 Cr₹0 Cr
Other assets₹49 Cr₹65 Cr₹111 Cr₹137 Cr₹135 Cr₹135 Cr
Total assets₹58 Cr₹74 Cr₹123 Cr₹159 Cr₹171 Cr₹172 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

The ownership split has held steady since Jun 2025. The shareholder count shrank 5% to 7,966.

Promoters
56.1%
Public
43.9%

Since Jun 2025

  • Public +0.01 pp
  • Promoters 0.00 pp
  • DIIs 0.00 pp

How it drifted, 12 quarters

Over this window promoters fell from 58.1% to 56.1% — −2.0 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 58.1%, Public 41.9%.Dec '23: Promoters 58.1%, Public 41.9%.Mar '24: Promoters 58.1%, Public 41.9%.Jun '24: Promoters 56.1%, Public 43.9%.Sep '24: Promoters 56.1%, DIIs 1.1%, Public 42.7%.Dec '24: Promoters 56.1%, DIIs 1.1%, Public 42.7%.Mar '25: Promoters 56.1%, DIIs 1.0%, Public 42.9%.Jun '25: Promoters 56.1%, Public 43.9%.Sep '25: Promoters 56.1%, Public 43.9%.Dec '25: Promoters 56.1%, Public 43.9%.Mar '26: Promoters 56.1%, Public 43.9%.Jun '26: Promoters 56.1%, Public 43.9%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Panchsheel Organic Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Rajesh Abhaychand Turakhia 16.16%unchanged
Kishore Abhaychand Turakhia 16.11%unchanged
Mahendra A Thrakhia 16.10%unchanged
Turakhia Mahendra Abhaychand Huf . 2.71%unchanged
Turakhia Rajesh Abhaychand Huf . 2.71%unchanged
Turakhia Kishor Abhaychand Huf . 2.33%unchanged
Dheeraj Kumar Lohia 2.17%+0.12 pp
Michael Dsouza 2.02%unchanged
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs 1.26%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Fair

To justify its price of ₹29, this stock must grow earnings at -16% every year for 7 years. Our analysis caps realistic growth at ~-16%. At that growth it is worth ₹28 — downside of 3%.

Growth the price implies
-15.7% a year
for 7 years, fading to 4%
It has actually compounded at
-12.4% a year
net profit, FY24–FY26 · EPS -16.3%
The gap
0.0 pp
-3% downside if it only repeats history
Price today ₹29 Value at the reference growth ₹28.06

Change the assumptions yourself →

Learn to analyse Panchsheel Organic Ltd.

Guides on how to read this kind of business and the numbers that matter.